Revenue of US$ 256.5 million Operating margin of 20.6% Diluted earnings per share of $1.55 BEVERLY, Mass., July 31, 2024 /PRNewswire/ — Axcelis TechnologiesNEW YORK, Jan....
BioSyent Inc. MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) today released its financial results for the three months (Q1)...